Injectable neuromuscular blockade in the treatment of spasticity and movement disorders.
about
Exploring strategies to prevent post-lobectomy space: transient diaphragmatic paralysis using Botulinum toxin type A (BTX-A).New clinical and research trends in lower extremity management for ambulatory children with cerebral palsyHow to improve the efficacy of endoscopic ultrasound-guided celiac plexus neurolysis in pain management in patients with pancreatic cancer: analysis in a single center.Treatment of Morton neuroma with botulinum toxin A: a pilot study.A Prospective Case-Control Study of Radial Extracorporeal Shock Wave Therapy for Spastic Plantar Flexor Muscles in Very Young Children With Cerebral Palsy.Evaluation of interadductor approach in neurolytic blockade of obturator nerve in spastic patients.The effect of obturator nerve block on hip lateralization in low functioning children with spastic cerebral palsy.Quantifying Effect of Onabotulinum Toxin A on Passive Muscle Stiffness in Children with Cerebral Palsy Using Ultrasound Shear Wave Elastography.Spread of Botulinum Neurotoxin Type A at Standard Doses Is Inherent to the Successful Treatment of Spastic Equinus Foot in Cerebral Palsy
P2860
Q24816864-ECAC9108-EE5F-4BFB-9C01-B58BC41F3BDBQ34302006-864A78AF-FAED-4025-9593-BDD177A8B3DFQ34337587-EE16A7F1-21F4-4D46-B4CF-D5BD20ABBE08Q36952082-587A1088-D177-40B8-8C27-1326C072D3FBQ36993558-0BE1D771-3AD7-48E4-8E56-EB298FA0380BQ37382010-9F113224-EB08-4FD7-88D1-A3B279A5E223Q37418824-343A3098-AF33-4FD6-9A2E-F90A59286F87Q50183776-2E5810FE-185B-4829-A004-AF6E68FA3258Q56781220-313C412A-2B4F-4C72-A9A3-B9F2A54C499A
P2860
Injectable neuromuscular blockade in the treatment of spasticity and movement disorders.
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Injectable neuromuscular blockade in the treatment of spasticity and movement disorders.
@ast
Injectable neuromuscular blockade in the treatment of spasticity and movement disorders.
@en
type
label
Injectable neuromuscular blockade in the treatment of spasticity and movement disorders.
@ast
Injectable neuromuscular blockade in the treatment of spasticity and movement disorders.
@en
prefLabel
Injectable neuromuscular blockade in the treatment of spasticity and movement disorders.
@ast
Injectable neuromuscular blockade in the treatment of spasticity and movement disorders.
@en
P2860
P1476
Injectable neuromuscular blockade in the treatment of spasticity and movement disorders.
@en
P2093
Ann H Tilton
P2860
P304
P356
10.1177/0883073803018001S0701
P478
18 Suppl 1
P577
2003-09-01T00:00:00Z